BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 32662640)

  • 1. 20
    Song J; Cui ZY; Lian LH; Han X; Hou LS; Wang G; Gao L; Zhu Y; Jiang YC; Dou JY; Hu ZH; Zhao YQ; Nan JX; Wu YL
    J Agric Food Chem; 2020 Aug; 68(31):8195-8204. PubMed ID: 32662640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P2X7R orchestrates the progression of murine hepatic fibrosis by making a feedback loop from macrophage to hepatic stellate cells.
    Jiang M; Cui BW; Wu YL; Zhang Y; Shang Y; Liu J; Yang HX; Qiao CY; Zhan ZY; Ye H; Jin Q; Nan JX; Lian LH
    Toxicol Lett; 2020 Oct; 333():22-32. PubMed ID: 32721574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disruption of TFGβ-SMAD3 pathway by the nuclear receptor SHP mediates the antifibrotic activities of BAR704, a novel highly selective FXR ligand.
    Carino A; Biagioli M; Marchianò S; Scarpelli P; Zampella A; Limongelli V; Fiorucci S
    Pharmacol Res; 2018 May; 131():17-31. PubMed ID: 29530598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Albiflorin ameliorates thioacetamide-induced hepatic fibrosis: The involvement of NURR1-mediated inflammatory signaling cascades in hepatic stellate cells activation.
    Song J; Qin BF; Feng QY; Zhang JJ; Zhao GY; Luo Z; Sun HM
    Ecotoxicol Environ Saf; 2024 May; 276():116334. PubMed ID: 38626607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatoprotection of yangonin against hepatic fibrosis in mice via farnesoid X receptor activation.
    Wang X; Fu T; Wang J; Wang C; Liu K; Wu J; Sun H; Ma X; Sun P; Meng Q
    Int Immunopharmacol; 2019 Oct; 75():105833. PubMed ID: 31450152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatoprotection of auraptene from peels of citrus fruits against thioacetamide-induced hepatic fibrosis in mice by activating farnesoid X receptor.
    Gao X; Wang C; Ning C; Liu K; Wang X; Liu Z; Sun H; Ma X; Sun P; Meng Q
    Food Funct; 2018 May; 9(5):2684-2694. PubMed ID: 29721568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ginsenoside Rd, a natural production for attenuating fibrogenesis and inflammation in hepatic fibrosis by regulating the ERRα-mediated P2X7r pathway.
    Cui L; Tan YJ; Xu SQ; Qin BF; Xiu MX; Zhang X; Shi LQ; Sun HM; Song J
    Food Funct; 2023 Jun; 14(12):5606-5619. PubMed ID: 37249244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probucol ameliorates hepatic stellate cell activation and autophagy is associated with farnesoid X receptor.
    Yang R; Hu Z; Zhang P; Wu S; Song Z; Shen X; Wei Z
    J Pharmacol Sci; 2019 Feb; 139(2):120-128. PubMed ID: 30638990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FXR agonist obeticholic acid reduces hepatic inflammation and fibrosis in a rat model of toxic cirrhosis.
    Verbeke L; Mannaerts I; Schierwagen R; Govaere O; Klein S; Vander Elst I; Windmolders P; Farre R; Wenes M; Mazzone M; Nevens F; van Grunsven LA; Trebicka J; Laleman W
    Sci Rep; 2016 Sep; 6():33453. PubMed ID: 27634375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Farnesoid X receptor critically determines the fibrotic response in mice but is expressed to a low extent in human hepatic stellate cells and periductal myofibroblasts.
    Fickert P; Fuchsbichler A; Moustafa T; Wagner M; Zollner G; Halilbasic E; Stöger U; Arrese M; Pizarro M; Solís N; Carrasco G; Caligiuri A; Sombetzki M; Reisinger E; Tsybrovskyy O; Zatloukal K; Denk H; Jaeschke H; Pinzani M; Trauner M
    Am J Pathol; 2009 Dec; 175(6):2392-405. PubMed ID: 19910507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentiation of hepatic stellate cell activation by extracellular ATP is dependent on P2X7R-mediated NLRP3 inflammasome activation.
    Jiang S; Zhang Y; Zheng JH; Li X; Yao YL; Wu YL; Song SZ; Sun P; Nan JX; Lian LH
    Pharmacol Res; 2017 Mar; 117():82-93. PubMed ID: 27940204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ginsenoside 25-OCH
    Han X; Song J; Lian LH; Yao YL; Shao DY; Fan Y; Hou LS; Wang G; Zheng S; Wu YL; Nan JX
    J Agric Food Chem; 2018 Jul; 66(27):7023-7035. PubMed ID: 29929367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angelica dahurica extract and its effective component bergapten alleviated hepatic fibrosis by activating FXR signaling pathway.
    Gao C; Hu ZH; Cui ZY; Jiang YC; Dou JY; Li ZX; Lian LH; Nan JX; Wu YL
    J Nat Med; 2024 Mar; 78(2):427-438. PubMed ID: 38334900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sesamol as a potential candidate for the treatment of hepatic fibrosis, based on its regulation of FXR/LXR axis-mediated inhibition of autophagy through crosstalk between hepatic cells and macrophage.
    Jiang Y; Hou L; Dou J; Xuan M; Cui Z; Lian L; Nan J; Wu Y
    Phytomedicine; 2024 Jan; 123():155145. PubMed ID: 37976698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of interleukin-1β-induced proliferation in rat hepatic stellate cells from different levels of signal transduction.
    Yaping Z; Ying W; Luqin D; Ning T; Xuemei A; Xixian Y
    APMIS; 2014 May; 122(5):392-8. PubMed ID: 23992404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of endothelin-1-mediated contraction of hepatic stellate cells by FXR ligand.
    Li J; Kuruba R; Wilson A; Gao X; Zhang Y; Li S
    PLoS One; 2010 Nov; 5(11):e13955. PubMed ID: 21085652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purinergic P2X7 receptor mediates acetaldehyde-induced hepatic stellate cells activation via PKC-dependent GSK3β pathway.
    Wu X; Wang Y; Wang S; Xu R; Lv X
    Int Immunopharmacol; 2017 Feb; 43():164-171. PubMed ID: 28061416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FXR agonist GW4064 alleviates endotoxin-induced hepatic inflammation by repressing macrophage activation.
    Yao J; Zhou CS; Ma X; Fu BQ; Tao LS; Chen M; Xu YP
    World J Gastroenterol; 2014 Oct; 20(39):14430-41. PubMed ID: 25339829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LPS-induced TNF-α factor mediates pro-inflammatory and pro-fibrogenic pattern in non-alcoholic fatty liver disease.
    Ceccarelli S; Panera N; Mina M; Gnani D; De Stefanis C; Crudele A; Rychlicki C; Petrini S; Bruscalupi G; Agostinelli L; Stronati L; Cucchiara S; Musso G; Furlanello C; Svegliati-Baroni G; Nobili V; Alisi A
    Oncotarget; 2015 Dec; 6(39):41434-52. PubMed ID: 26573228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SUMOylation inhibitors synergize with FXR agonists in combating liver fibrosis.
    Zhou J; Cui S; He Q; Guo Y; Pan X; Zhang P; Huang N; Ge C; Wang G; Gonzalez FJ; Wang H; Hao H
    Nat Commun; 2020 Jan; 11(1):240. PubMed ID: 31932588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.